Search

Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons

Trial Phase 1 Recruiting March 24, 2026

Severity of Sarcopenia in Parkinson's Disease

Trial N/A Completed March 24, 2026

Cortical-Basal Ganglia Speech Networks

Trial N/A Recruiting March 24, 2026

Observational Study Evaluating Robotic Spinal Mobilization in 16 Parkinson's Disease Participants. The Study Recorded Changes in Mobility, Sit-to-stand Performance, and Pain Scores After a 2-week Intervention With the BackHug Device.

Trial N/A Completed March 24, 2026

Tango!

News Parking Suns March 24, 2026

Gastroparesis and Parkinson’s disease

News A Closer Look Archives | American Parkinson Disease Association March 24, 2026

Smartphone-Based Digital Phenotyping Across Health Conditions: Scoping Review.

Research Journal of medical Internet research March 24, 2026

Effects of AMPS on Cardiovascular and Functional Variables in Patients With Parkinson's Disease

Trial N/A Completed March 23, 2026

Respiratory Functions in Parkinson's Disease

Trial N/A Recruiting March 23, 2026

Brain Activity, Cognitive Function, and Walking Ability in Parkinson's Disease

Trial N/A Recruiting March 23, 2026

A Study to Evaluate the Safety and Efficacy of ExAblate Subthalomotomy for the Treatment of Parkinson's Disease Motor Features

Trial N/A Completed March 23, 2026

Context- and Terrain-aware Gait Analysis

Trial N/A Withdrawn March 23, 2026

In Vivo Measurement of the Accuracy of the "Neurolocate" Module of the Neurosurgical Robot "Neuromate" in Its Application to Deep Brain Stimulation

Trial N/A Completed March 23, 2026

"Self-Compassion and Self-Efficacy in Parkinson's Disease: Associations With Symptoms, Function, and Quality of Life"

Trial N/A Not yet recruiting March 22, 2026

Targeting Apathy With Music in Parkinson's Disease

Trial N/A Recruiting March 22, 2026

Early Parkinson's Disease Monotherapy With CVN424

Trial Phase 2 Completed March 22, 2026

Cue X as a Treatment for People With Parkinson's Disease

Trial N/A Completed March 22, 2026

A Clinical Study of Dihydroergotine Mesylate Extended-release Tablets for the Treatment of Drooling in Parkinson's Disease.

Trial Phase 4 Completed March 22, 2026

Effects of the Stimulation Site of tsMS With TMS on Functional Mobility in Individuals With Parkinson's Disease

Trial N/A Recruiting March 22, 2026

Determinants of Physical Frailty in Parkinson's Disease: A Multi-Factorial Analysis

Trial N/A Not yet recruiting March 22, 2026